文献速递细菌感染、耐药与抗菌药物医院感染防控

COVID-19大流行对一家专科儿科医院抗菌药物处方的影响:一项观察性研究

The impact of the COVID-19 pandemic on antimicrobial prescribing at a specialist paediatric hospital: an observational study.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该研究基于伦敦一家三级儿科医院2019年4月29日至2021年3月28日的住院患者电子健康记录,采用中断时间序列分析评估COVID-19大流行对抗生素治疗天数和WHO「可及」类抗生素处方比例的影响,共纳入23292例住院。大流行前平均每周262例入院,大流行期间212例;粗算抗生素治疗天数从每周801增至846,可及类抗生素比例从44%降至42%;但控制患者特征变化后,无证据表明大流行对抗生素处方有影响。

要点

  • 大流行前平均每周262例入院,大流行期间212例,患者人口学特征相似但收治专科分布有变化。
  • 粗算抗生素治疗天数从大流行前每周801增至大流行期间846,可及类抗生素比例从44%降至42%。
  • 控制患者特征变化后,无证据表明COVID-19大流行对抗生素处方有显著影响。

核心结论

  • 一家专科儿童医院的患者人群受到COVID-19大流行影响,但调整这些变化后,无证据表明抗生素处方受到大流行的显著影响。

研究设计与样本

  • 观察性研究,从电子健康记录中提取2019年4月29日至2021年3月28日期间住院患者特征和抗菌药物使用数据,共纳入23292例住院,采用中断时间序列分析评估抗生素治疗天数和WHO「可及」类抗生素处方比例。

主要发现

  • 大流行前平均每周262例入院,大流行期间212例;两个时期患者人口学特征相似,但收治专科分布有变化。
  • 大流行期间抗生素治疗天数粗算从大流行前每周801增至846,可及类抗生素比例从44%降至42%。
  • 控制患者特征变化后,无证据表明大流行对抗生素处方有影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The COVID-19 pandemic has severely impacted healthcare delivery and there are growing concerns that the pandemic will accelerate antimicrobial resistance. OBJECTIVES: To evaluate the impact of the COVID-19 pandemic on antibiotic prescribing in a tertiary paediatric hospital in London, UK. METHODS: Data on patient characteristics and antimicrobial administration for inpatients treated between 29 April 2019 and Sunday 28 March 2021 were extracted from the electronic health record (EHR). Interrupted time series analysis was used to evaluate antibiotic days of therapy (DOT) and the proportion of prescribed antibiotics from the WHO 'Access' class. RESULTS: A total of 23 292 inpatient admissions were included. Prior to the pandemic there were an average 262 admissions per week compared with 212 during the pandemic period. Patient demographics were similar in the two periods but there was a shift in the specialities that patients had been admitted to. During the pandemic, there was a crude increase in antibiotic DOTs, from 801 weekly DOT before the pandemic to 846. The proportion of Access antibiotics decreased from 44% to 42%. However, after controlling for changes in patient characteristics, there was no evidence for the pandemic having an impact on antibiotic prescribing. CONCLUSIONS: The patient population in a specialist children's hospital was affected by the COVID-19 pandemic, but after adjusting for these changes there was no evidence that antibiotic prescribing was significantly affected by the pandemic. This highlights both the value of routine, high-quality EHR data and importance of appropriate statistical methods that can adjust for underlying changes to populations when evaluating impacts of the pandemic on healthcare.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Vestesson E, Booth J, Hatcher J, et al. The impact of the COVID-19 pandemic on antimicrobial prescribing at a specialist paediatric hospital: an observational study. J Antimicrob Chemother. 2022. PMID: 35134183. doi:10.1093/jac/dkac009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。